Novel technique may significantly reduce breast biopsies

 

OAK BROOK, Ill., USA (December 11, 2018)  – A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce unnecessary breast biopsies, according to a new study appearing in the journal Radiology. Mammography has been effective at reducing deaths from breast cancer by detecting cancers in their earliest, most treatable stages. However, many women are called back for additional diagnostic imaging and, in many cases, biopsies, for abnormal findings that are ultimately proven benign. Research estimates this recall rate to be more than 10 percent in the United States.

„The callback rate with mammography is much higher than ideal,“ said the study’s first author, Karen Drukker, Ph.D., research associate professor from the Department of Radiology at the University of Chicago in Chicago. „There are costs and anxiety associated with recalls, and our goal is to reduce these costs but not miss anything that should be biopsied.“

Dr. Drukker and colleagues recently studied a new technique called three-compartment breast (3CB) imaging. John Shepherd, Ph.D., currently at the University of Hawaii in Honolulu, and his team developed 3CB while he was at the University of California in San Francisco. By measuring the water, lipid and protein tissue composition throughout the breast, 3CB might provide a biological signature for a tumor. For instance, more water in the tumor tissue might indicate angiogenesis, or the production of new blood vessels, an early sign of cancer development.

For the study, the researchers acquired dual-energy mammograms from 109 women with breast masses that were suspicious or highly suggestive of a malignancy–the types of lesions that typically would be biopsied–immediately prior to biopsy, and the ensuing biopsies showed 35 masses to be invasive cancers, while the remaining 74 were benign.

3CB images were derived from the dual-energy mammograms and analyzed along with mammography radiomics, a method that uses artificial intelligence algorithms to analyze features and patterns in images–some of which are difficult for human perception–developed by Maryellen L. Giger, Ph.D., and her team at the University of Chicago for use in computer-aided diagnosis on breast images.

The combination of 3CB image analysis and radiomics improved the positive predictive value, or the ability to predict cancer, in breast masses deemed suspicious by the breast radiologist. The combined method improved positive predictive value from 32 percent for visual interpretation alone to almost 50 percent, with an almost 36 percent reduction in biopsies. The 3CB-radiomics method missed one of the 35 cancers, for a 97 percent sensitivity rate.

„These results are very promising,“ Dr. Drukker said. „Combining 3CB image analysis with mammography radiomics, the reduction in recalls was substantial.“

Dr. Drukker said the combined 3CB-radiomics approach has the potential to play an increasingly prominent role in breast cancer diagnosis and perhaps also screening. She noted that 3CB can easily be added to mammography without requiring extensive modifications of existing equipment.

„The patient is already getting the mammography, plus we get all this extra information with only a 10 percent additional dose of radiation,“ she said.

This approach is still experimental at this stage, and further work is needed to make it available to patients. The researchers plan to study how the combined approach will help radiologists make their final determinations. They also want to study the approach using digital breast tomosynthesis, sometimes called „3D“ mammography, which reduces the problem of overlapping breast tissue inherent to regular mammography. A tumor’s unique water-lipid-protein signature might be even clearer with tomosynthesis, Dr. Drukker said.

 

„Combined Benefit of Quantitative Three-Compartment Breast Image Analysis and Mammography Radiomics in the Classification of Breast Masses in a Clinical Data Set.“ Collaborating with Drs. Drukker, Shepherd and Giger were Bonnie N. Joe, M.D., Karla Kerlikowske, M.D., Heather Greenwood, M.D., Jennifer S. Drukteinis, M.D., Bethany Niell, M.D., Bo Fan, Ph.D., Serghei Malkov, Ph.D., Jesus Avila, B.S., and Leila Kazemi, B.S.

Radiology is edited by David A. Bluemke, M.D., Ph.D., University of Wisconsin School of Medicine and Public Health, Madison, Wis., and owned and published by the Radiological Society of North America, Inc.

RSNA is an association of over 54,000 radiologists, radiation oncologists, medical physicists and related scientists promoting excellence in patient care and health care delivery through education, research and technologic innovation. The Society is based in Oak Brook, Ill. (RSNA.org)

 

IMAGE: Images in 71-year-old woman with 1.6-cm invasive ductal carcinoma (Breast Imaging Reporting and Data System category 5, with category C breast density). Low-energy mammogram and corresponding regions of interest for mammogram (top) and breast tissue composition images (bottom two rows). Credit: Radiological Society of North America

 


Radiological Society of North America, 11.12.2018 (tB).

Schlagwörter: , ,

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…
Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Nahrungsergänzungsmittel während der Krebstherapie: Es braucht mehr Bewusstsein für mögliche…
Fusobakterien und Krebs
Fortgeschrittenes Zervixkarzinom: Pembrolizumab verlängert Leben
Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…